Dagondon, Julie S.

HRN: 22-89-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2023
CEFUROXIME 750MG (VIAL)
07/09/2023
07/15/2023
IVT
750mg
Q8
Pleomorphic Adenoma Parotid Gland Left

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines